Preclinical Aspects of [<sup>89</sup>Zr]Zr-DFO-Rituximab: A High Potential Agent for Immuno-PET Imaging
[<sup>89</sup>Zr]Zr-DFO-Rituximab represents a significant advancement in the field of oncological imaging and offers a robust platform for both diagnostic and therapeutic applications in the management of B-cell malignancies.
Authors
- Behrouz Alirezapour (ORCID: https://orcid.org/0000-0003-2403-8049)
- Ali Moghaddasi
- Samaneh Zolghadri (ORCID: https://orcid.org/0000-0003-4060-328X)
- Hassan Yousefnia (ORCID: https://orcid.org/0000-0002-7112-3847)
- Seyed Mahmoud Reza Aghamiri
- Zahra Rouhollahi
Institutions
- Atomic Energy Organization of Iran (IR)
- Nuclear Science and Technology Research Institute
- Shahid Beheshti University (IR)
Publication Details
- Journal
- Current Radiopharmaceuticals
- Published
- 2024-10-25
- DOI
- https://doi.org/10.2174/0118744710326742241018050220
- Citations
- 2
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.81